CJC-1295 vs NAD+

CJC-1295 and NAD+ are both widely studied research peptides, but they differ significantly in mechanism, application, and research focus.

CJC-1295

CJC-1295 is a growth-focused peptide that has been extensively studied in laboratory settings. Its specific mechanism makes it particularly suited for certain research applications.

NAD+

NAD+ operates through a different pathway, focusing on longevity-related biological processes. Researchers choose between these compounds based on their specific experimental objectives.

Key Differences

The primary differences lie in receptor selectivity, half-life, and downstream effects. Some protocols may benefit from using both compounds to investigate complementary pathways.

Both Available at Proxiva

Proxiva Peptides offers both CJC-1295 and NAD+ at 99.9% verified purity with COA included.

Browse our full research peptide catalog at Proxiva Peptides.

All products are for laboratory and research use only. Not for human consumption.